Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-gamma + THP in HER2+ Breast Cancer
NCT03112590Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jun 2017
- Primary completion
- Mar 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in breast cancer, sponsored by Moffitt Cancer Center. Started Jun 2017; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03112590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112590.